PUMA BIOTECHNOLOGY INC (PBYI)

US74587V1070 - Common Stock

5.02  +0.14 (+2.87%)

After market: 5.02 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
235.64M228.00M253.20M225.10M272.30M
Cost Of Goods
62.68M55.10M63.70M39.40M36.80M
Gross Profit
172.96M172.90M189.50M185.70M235.40M
Operating Expenses
139.69M149.20M188.20M216.10M273.40M
Research and Development
50.38M59.20M71.90M97.70M132.90M
Selling, General, and Administrative Expenses
89.31M90.00M116.30M118.50M140.50M
Operating Income
33.27M23.80M1.30M-30.40M-37.90M
Interest Income/Expense
-10.72M-10.80M-12.60M-13.60M-12.20M
Other Income/Expense
759.00K0.00300.00K400.00K100.00K
Non Recurring Items
-625.00K-12.50M-17.70M-16.20M-25.60M
Income Before Taxes
22.67M500.00K-28.80M-59.80M-75.50M
Income Tax
1.08M500.00K300.00K200.00K100.00K
Net Income
21.59M0.00-29.10M-60.00M-75.60M
EBITDA
44.78M32.72M11.90M-20.37M-29.82M
 
Per Share Data
EPS Diluted Total Ops
0.450.00-0.72-1.52-1.95
Non GAAP EPS
0.46-0.00-0.53-1.52-1.96
 
Statistics
Gross Profit Margin
73.40%75.83%74.84%82.50%86.45%
Profit Margin
9.16%N/A-11.49%-26.65%-27.76%
Operating Profit Margin
14.12%10.44%0.51%-13.51%-13.92%

All data in USD

Charts